Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stohr

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursorsRuhollah Moussavi-Baygi, Matthew J Ryan, Woogwang Sim, et al.
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulatorHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics|November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancerHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursorsRuhollah Moussavi-Baygi, Matthew J Ryan, Woogwang Sim, et al.
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulatorHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics|November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancerHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Pageof 7